Viewing Study NCT01818492


Ignite Creation Date: 2025-12-24 @ 3:35 PM
Ignite Modification Date: 2025-12-29 @ 6:46 AM
Study NCT ID: NCT01818492
Status: COMPLETED
Last Update Posted: 2023-02-21
First Post: 2013-03-21
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Study to Investigate Safety, Efficacy of an Anti-IFNγ mAb in Children With Primary Haemophagocytic Lymphohistiocytosis
Sponsor: Swedish Orphan Biovitrum
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: NI-0501-04
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None OTHER View